Last reviewed · How we verify
Intra-articular secretome injection therapy
Intra-articular secretome injection therapy is a Biologic drug developed by Kementerian Riset dan Teknologi / Badan Riset dan Inovasi Nasional, Indonesia. It is currently in Phase 1 development.
At a glance
| Generic name | Intra-articular secretome injection therapy |
|---|---|
| Sponsor | Kementerian Riset dan Teknologi / Badan Riset dan Inovasi Nasional, Indonesia |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Mesenchymal Stem Cell Therapy (MSCs) and Conditioned Medium Therapy for Osteoartrithis (PHASE1, PHASE2)
- Investigating the Safety and Regenerative Potential of MSC-Derived Secretome Combined With PRGF in Knee Osteoarthritis (EARLY_PHASE1)
- Effectivity of Allogenic Umbilical Cord Mesenchymal Stem Cells Conditioned Media for Osteoarthritis of the Knee Joint (PHASE1, PHASE2)
- Effectiveness of PRP, Conditioned Medium UC-MSCs Secretome and Hyaluronic Acid for the Treatment of Knee Osteoarthritis (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Intra-articular secretome injection therapy CI brief — competitive landscape report
- Intra-articular secretome injection therapy updates RSS · CI watch RSS
- Kementerian Riset dan Teknologi / Badan Riset dan Inovasi Nasional, Indonesia portfolio CI
Frequently asked questions about Intra-articular secretome injection therapy
What is Intra-articular secretome injection therapy?
Intra-articular secretome injection therapy is a Biologic drug developed by Kementerian Riset dan Teknologi / Badan Riset dan Inovasi Nasional, Indonesia.
Who makes Intra-articular secretome injection therapy?
Intra-articular secretome injection therapy is developed by Kementerian Riset dan Teknologi / Badan Riset dan Inovasi Nasional, Indonesia (see full Kementerian Riset dan Teknologi / Badan Riset dan Inovasi Nasional, Indonesia pipeline at /company/kementerian-riset-dan-teknologi-badan-riset-dan-inovasi-nasional-indonesia).
What development phase is Intra-articular secretome injection therapy in?
Intra-articular secretome injection therapy is in Phase 1.